As a result, medications that target lymphocyte growth or apoptosis, such as interleukin IL-2, IL-7, or programmed cell death protein 1 (PD1/PD-L1) inhibitors, may be able to assist in avoiding lymphopenia or in restoring lymphocyte levels in very ill patients [116]. Here, PDCD1 is linked to lymphopenia.